This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Julie Vickers
Advertisement
Julie Vickers is a subject matter expert in Process Engineering at Jacobs.
Articles by Julie Vickers
Advertisement
Latest Updated Articles
Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine ManufacturingPublished: August 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
